On November 23, 2020, the US Food and Drug Administration (FDA) has granted the Innovita antibody kit an Emergency Use Authorization (EUA). The Innovita 2019-nCoV Ab Test (Colloidal Gold) is deemed as an instrumental diagnostic technology against the public health emergency caused by the COVID-19 pandemic. Below is the FDA report citing the reliability of the Innovita rapid test kits.
As a globally renowned test, the Innovita antibody kit is capable of aiding our country’s COVID-19 detection and isolation efforts for positive cases. For accredited testing organizations and LGUs interested in purchasing our Innovita kit, please feel free to fill out the form below.
